'Pharma Bro' Martin Shkreli Cannot Return To Drug Industry Ever: Court Upholds Lifetime Ban
Shkreli, also known as "Pharma Bro," gained notoriety in 2015 when, as the CEO of Turing Pharmaceuticals, he hiked the price of Daraprim from $17.50 to $750 per tablet.
